Impact Report 2023

The Paterson building Charitable donations allowed us to part fund a world leading £150m research centre that opened this year in partnership with The University of Manchester and Cancer Research UK. The building is part of the Manchester Cancer Research Centre and will be one of the top cancer research centres in the world. The centre replaces a previous building that was severely damaged by fire six years ago. It is directly connected to the hospital, allowing cells and samples from patients to be taken to the research lab in a matter of minutes. The ambition is to foster collaboration, double the number of patients benefitting from clinical trials by 2030 and ultimately improve outcomes and survival rates. Together, a multidisciplinary team of scientists, researchers, clinicians, and operational staff – practising what is known as ‘team science’ – will deliver clinical trials covering the full extent of the patient pathway, from prevention and novel treatments to living with and beyond cancer.

A central component of the building is a new Cancer Biomarker Centre, which will focus on genes, proteins and other cancer-associated molecules – to aid in early cancer detection and diagnosis – and biomarkers that enable personalised management of a patient’s cancer, to determine which therapy will bring the most benefit. The centre will be Manchester’s scientific headquarters for the Alliance for Early Cancer Detection and will also house a team focused on global genomics, or how cancer presents differently in people from different racial and ethnic backgrounds.

THE AMBITION IS TO DOUBLE THE NUMBER OF PATIENTS BENEFITTING FROM CLINICAL TRIALS BY 2030

13